niacinamide has been researched along with warfarin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kohda, T; Oishi, M; Yamagoe, S | 1 |
| Aonuma, S; Nagao, M; Nakayasu, M; Shima, H; Sugimura, T | 1 |
| Ahronson, Z; Goldschmied, A; Joseph, B; Mishkinsky, JS; Sulman, FG | 1 |
| MARTINI, V | 1 |
| Montalvo, RO; Moretti, LV | 1 |
| Hara, F; Hirano, N; Iida, K; Ishii, K; Kikuchi, Y; Shiozawa, K; Sumino, Y; Wakui, N; Watanabe, M | 1 |
| Bourbon, P; Ferraudi, G; Helquist, P; Peng, Q; Stauffacher, C; Wiest, O | 2 |
| Daroji, VK; Hillemane, V; Jayashree, BS; Nayak, Y; Unnikrishnan, MK | 1 |
| Callaghan, C; Dash, S; Lee, BR; Liu, J; Maddox, M; Mandava, SH; Peralta, D; Tarr, MA | 1 |
| Becker, KG; Bohr, VA; Fang, EF; Fivenson, EM; Li, C; Morevati, M; Waltz, TB | 1 |
| Hoch, M; Hourcade-Potelleret, F; Sengupta, T | 1 |
1 review(s) available for niacinamide and warfarin
| Article | Year |
|---|---|
Sarcopenia, Aging and Prospective Interventional Strategies.
Topics: Aging; Animals; Coumarins; Humans; Mitochondria; Molecular Structure; Niacinamide; Sarcopenia; Tomatine | 2018 |
1 trial(s) available for niacinamide and warfarin
| Article | Year |
|---|---|
Pharmacokinetic drug interactions of asciminib with the sensitive cytochrome P450 probe substrates midazolam, warfarin, and repaglinide in healthy participants.
Topics: Carbamates; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Healthy Volunteers; Humans; Midazolam; Niacinamide; Piperidines; Pyrazoles; Warfarin | 2022 |
11 other study(ies) available for niacinamide and warfarin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Poly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression at the posttranscriptional level.
Topics: Benzamides; beta-Galactosidase; Blotting, Northern; Chloramphenicol O-Acetyltransferase; Coumarins; Gene Expression; Genes, tat; Genes, Viral; HeLa Cells; HIV-1; Humans; Kinetics; Niacinamide; Plasmids; Poly(ADP-ribose) Polymerase Inhibitors; Restriction Mapping; Transcription, Genetic; Transfection; Ultraviolet Rays | 1991 |
Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide.
Topics: Benzamides; Blotting, Southern; Cell Differentiation; Cell Line; Coumarins; Dimethyl Sulfoxide; Gene Amplification; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Nucleic Acid Hybridization; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; Quinazolines; Quinazolinones; RNA, Neoplasm | 1989 |
Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis (leguminosae) seeds and their major alkaloids in alloxan-diabetic and normal rats.
Topics: Alkaloids; Animals; Azocines; Blood Glucose; Carbon Radioisotopes; Coumarins; Diabetes Mellitus, Experimental; Diuresis; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Niacinamide; Nicotinic Acids; Plant Extracts; Plants; Plants, Medicinal; Rats; Seeds; Sparteine | 1974 |
[Factors of growth and metamorphosis of tadpoles. IV. Action of nicotinamide and coumarin].
Topics: Animals; Coumarins; Growth; Humans; Larva; Metamorphosis, Biological; Niacin; Niacinamide | 1950 |
Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
Topics: Aged; Anticoagulants; Benzenesulfonates; Carcinoma, Hepatocellular; Drug Interactions; Hemorrhage; Humans; International Normalized Ratio; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Warfarin | 2009 |
[Gastrointestinal hemorrhage associated with concurrent use of sorafenib and warfarin for hepatocellular carcinoma].
Topics: Anticoagulants; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tomography, X-Ray Computed; Warfarin | 2011 |
Synthesis, photophysical, photochemical, and computational studies of coumarin-labeled nicotinamide derivatives.
Topics: Coumarins; Crystallography, X-Ray; Molecular Structure; Niacinamide; Photochemistry; Quantum Theory | 2012 |
Development of carbamate-tethered coumarins as phototriggers for caged nicotinamide.
Topics: Carbamates; Coumarins; Niacinamide; Photochemical Processes | 2013 |
Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
Topics: Animals; Biomarkers; Blood Glucose; Coumarins; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fasting; Glucose Tolerance Test; Glycation End Products, Advanced; Glycogen; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Liver; Male; Niacinamide; Oxidative Stress; Pancreas; Rats, Wistar; Streptozocin | 2014 |
Combined Treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Coumarins; Drug Compounding; Gold; Humans; Kidney Neoplasms; Lasers; Nanotubes; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Serum Albumin; Solubility; Sorafenib | 2016 |